Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease ; volume:242 ; number:1 ; day:1 ; month:11 ; year:2023 ; pages:25-32 ; date:1.2024
Experimental brain research ; 242, Heft 1 (1.11.2023), 25-32, 1.2024
- Creator
-
Shen, Yufei
Zhu, Zhuoying
Wang, Yanping
Qian, Shuxia
Xu, Congying
Zhang, Baorong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00221-023-06709-3
- URN
-
urn:nbn:de:101:1-2024032515173722663994
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shen, Yufei
- Zhu, Zhuoying
- Wang, Yanping
- Qian, Shuxia
- Xu, Congying
- Zhang, Baorong
- SpringerLink (Online service)
Other Objects (12)
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Role of the ubiquitin proteasome system in Parkinson's disease
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models
Parkinson
Parkinson
MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease